SurGraft® AC is a meticulously designed, dual-layer amnion/chorion derived placental allograft. The properties of these avascular membranes provide enhanced handling.
SurGraft® AC is processed in compliance with the United States Food and Drug Administration current Good Tissue Practices (cGTP) Regulations and the American Association of Tissue Banks Standards. We pride ourselves on quality and testing that meet or exceed industry standards.
SurGraft® AC has been shown to be effective as a protective covering in the management of chronic non-healing ulcers including diabetic, pressure, and venous ulcers. Our allografts support enhanced tissue adherence along with heightened strength and effortless handling.
SurGraft® AC is regulated under Section 361 of the PHS Act and FDA 21 CFR Part 1271 and is intended for homologous use.
HCPCS Level II Code Q4393, "SurGraft AC, per square centimeter"
